← All tickers

Is MNKD Worth Buying in 2026?

Mannkind Corporation

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-07-26

Here’s whether Mannkind Corporation (MNKD) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.

🔵
Neutral

Positives: above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+4.78% over 10 days); RSI 45 — healthy momentum range; 3-month momentum positive (+53.0%). Concerns: trading below the 200-day MA (long-term downtrend). Currently 36.6% off its 52-week high. Score: +2/7.

Ready to act on this? 📈 Trade on Webull

MNKD is trading below its 200-day MA ($4.37) — a key warning sign the longer-term trend is under pressure. An RSI of 44.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +1.2% compares to +16.5% for SPY (trailed the market by 15.2%). The current 36.6% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $10,123 today
vs. S&P 500 (SPY) — same period trailed market by 15.2%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✗Above 200-day MA ($4.37)
✓Above 50-day MA ($3.77)
✓RSI(14) neutral zone (30–70) — currently 44.8
✓Positive return (+1.2%)
!Within 10% of period high (−36.6%)
Period Range $4.13
$2.23 $6.51
RSI (14) 44.8
0 · OversoldOverbought · 100

Key Metrics

Price$4.13
Period Return+1.2%
Period High$6.51
Period Low$2.23
Drawdown−36.6%
MA-50$3.77
MA-200$4.37
RSI (14)44.8
Avg Volume (30d)5.1M
vs. SPYtrailed by 15.2%
Return Rank#510 of 999

Trade MNKD

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers